Skip to main content
HealthReportedMediumDeveloping
4.7

Experimental Pancreatic Cancer Drug Halts Tumor Growth in 90% of Phase I/II Patients

An experimental drug combined with chemotherapy stopped tumor growth in 90% of pancreatic cancer patients in a phase I/II trial, with one of 12 showing undetectable tumors on imaging. Specialists caution that larger studies and longer follow-up are needed to assess durability. This is an early-stage signal, not a proven therapy.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

Digi24about 17 hours agoCredibility 29%View source

Score Breakdown

Mosaic Score4.7
Model confidence0.3
Significance0.5
Source credibility0.3
Source

Related signals

8 found